Literature DB >> 22484845

Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.

M J McKenna1, B Murray, R Lonergan, J M T Redmond.   

Abstract

BACKGROUND: The effect of immunomodulator therapy (IMT) for multiple sclerosis (MS) on bone turnover is unknown. AIM: The aim of this study was to assess bone turnover in MS patients on IMT.
METHODS: MS patients (n = 29) on maintenance IMT had repeat measurement of bone mineral density (BMD) after a 4.0 ± 0.4 years; bone turnover markers (BTM) were measured at the time of repeat BMD.
RESULTS: BMD was unchanged at the spine but declined at the hip. BTMs, both resorption and formation, were reduced compared to normative range that may indicate an anti-resorptive action of IMT. Significant negative correlations were noted between BTMs and changes in BMD at spine but not hip.
CONCLUSION: These observations suggest that IMT may have a beneficial effect on spinal bone by an antiresorptive action. A prospective study of the effect of IMT on BMD and bone turnover is warranted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484845     DOI: 10.1007/s11845-012-0818-5

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  17 in total

1.  Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.

Authors:  A T Reder; G C Ebers; A Traboulsee; D Li; D Langdon; D S Goodin; T Bogumil; K Beckmann; A Konieczny
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

2.  Comment on Shuhaibar et al.: Favourable effect of immunomodulator therapy on bone mineral density in multiple sclerosis.

Authors:  M T Kampman; L H Steffensen
Journal:  Ir J Med Sci       Date:  2009-01-31       Impact factor: 1.568

3.  Improving standards of DXA.

Authors:  M J McKenna; S van der Kamp; M Au-Yeong; O FitzGerald
Journal:  Ir Med J       Date:  2008-04

Review 4.  Clinical Review: The 2011 report on dietary reference intake for vitamin D: where do we go from here?

Authors:  John F Aloia
Journal:  J Clin Endocrinol Metab       Date:  2011-07-27       Impact factor: 5.958

5.  The prevalence and management of vitamin D deficiency in an acute geriatric unit.

Authors:  M McKenna; R Freaney; D Keating; F P Muldowney
Journal:  Ir Med J       Date:  1981-11

6.  The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients.

Authors:  Asuman Orhan Varoglu; Erhan Varoglu; Rezzan Bayraktar; Recep Aygul; Hizir Ulvi; Kadir Yildirim
Journal:  J Back Musculoskelet Rehabil       Date:  2010       Impact factor: 1.398

7.  Proximal femur bone mineral levels of US adults.

Authors:  A C Looker; H W Wahner; W L Dunn; M S Calvo; T B Harris; S P Heyse; C C Johnston; R L Lindsay
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

8.  The effect of narrowband UV-B treatment for psoriasis on vitamin D status during wintertime in Ireland.

Authors:  Caitriona Ryan; Benvon Moran; Malachi J McKenna; Barbara F Murray; Jennifer Brady; Paul Collins; Sarah Rogers; Brian Kirby
Journal:  Arch Dermatol       Date:  2010-08

Review 9.  Vitamin D and bone health in the elderly.

Authors:  A M Parfitt; J C Gallagher; R P Heaney; C C Johnston; R Neer; G D Whedon
Journal:  Am J Clin Nutr       Date:  1982-11       Impact factor: 7.045

10.  Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women.

Authors:  Kavinderjit S Nanda; Elizabeth J Ryan; Barbara F Murray; Jennifer J Brady; Malachi J McKenna; Niamh Nolan; Cliona O'Farrelly; John E Hegarty
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-24       Impact factor: 11.382

View more
  1 in total

1.  High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Authors:  Trygve Holmøy; Jonas Christoffer Lindstrøm; Erik Fink Eriksen; Linn Hofsøy Steffensen; Margitta T Kampman
Journal:  BMC Neurol       Date:  2017-04-04       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.